ELEVAI Labs Expands Into European Market With Signing of New Partnership
The Company's New Strategic Partnership With Premier Luxury Skincare Distributor Skin Sana Ltd. Will See ELEVAI Enter the European Market With its Topical Exosome Skincare Products
ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce its new partnership with Skin Sana Ltd. a Serbian corporation and premier luxury skincare distributor based in Belgrade covering territories that include Serbia, Albania, North Macedonia, Kosovo and Bosnia-Herzegovina. This strategic collaboration is the company’s first in Europe and marks the beginning of a robust relationship bringing ELEVAI’s topical exosome products to the region.
Chris Kraneiss, Chief Commercial Officer of ELEVAI Labs commented on the company’s new partnership, stating:
Source: ELEVAI Skincare YouTube
Also Read: ELEVAI Labs Closes $6 Million NASDAQ IPO
Also commenting on the new strategic collaboration, Skin Sana CEO Vera Petkovic had the following to say:
Dr. Aleksandra Markoski Smiljkovic, CEO and founder of Rejuva Laser and Aesthetic Belgrade in Serbia, remarked on becoming the first Serbian clinic to offer its patients ELEVAI’s innovative topical exosome products, stating:
Shares of ELEVAI Labs (NASDAQ: ELAB) last traded at $2.13 per share.
Learn more about ELEVAI Labs: Website | Investor Deck | ELAB Chart
Follow ELEVAI on Social Media: Instagram | LinkedIn | Facebook | Twitter | YouTube
Join the Discussion in the Wealthy VC Investor Group
Have a Stock Tip or New Story Suggestion? Email us at Invest@WealthyVC.com
Elevai Labs Inc. is a paid client of Wealthy VC.
This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below.